Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 59 of 62
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Genentech, Affimed sign $5bn cancer deal

As part of the deal, Affimed will authorize its redirected optimized cell killing (ROCK) platform to discover and optimize innate immune cell engager-based immunotherapeutics of interest to Genentech.

Lupin introduces contraceptive drug in US

The company has secured approval from the Food and Drug Administration for drugs with strengths of 3 mg/0.02 mg/0.451 mg and 0.451 mg (EQ Beyaz). Lupin’s Drospirenone, Ethinyl